Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 In vitro activity of anidulafungin against Candida albicans biofilms.

Literature DB >> 18391031

In vitro activity of anidulafungin against Candida albicans biofilms.

Melissa J Jacobson¹, Kerryl E Piper, Gary Nguyen, James M Steckelberg, Robin Patel.

Abstract

We tested the activity of anidulafungin against 30 Candida albicans isolates. The planktonic MICs for 50 and 90% of the isolates tested (MIC(50) and MIC(90)) were < or =0.03 and 0.125 microg/ml, respectively (MIC range, < or =0.03 to 2 microg/ml). The sessile MIC(50) and MIC(90) were < or =0.03 and < or =0.03 microg/ml, respectively (MIC range, < or =0.03 to >16 microg/ml).

Entities: Chemical Species

Mesh：

Substances：

Year: 2008 PMID： 18391031 PMCID： PMC2415795 DOI： 10.1128/AAC.00211-08

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

8 in total

Review 1. Guidelines for the management of intravascular catheter-related infections.

Authors: L A Mermel; B M Farr; R J Sherertz; I I Raad; N O'Grady; J S Harris; D E Craven
Journal: Clin Infect Dis Date: 2001-04-03 Impact factor: 9.079

2. Differential activities of newer antifungal agents against Candida albicans and Candida parapsilosis biofilms.

Authors: Aspasia Katragkou; Athanasios Chatzimoschou; Maria Simitsopoulou; Maria Dalakiouridou; Eudoxia Diza-Mataftsi; Chaido Tsantali; Emmanuel Roilides
Journal: Antimicrob Agents Chemother Date: 2007-10-15 Impact factor: 5.191

3. Evaluation of caspofungin and amphotericin B deoxycholate against Candida albicans biofilms in an experimental intravascular catheter infection model.

Authors: Jennifer A Shuford; Mark S Rouse; Kerryl E Piper; James M Steckelberg; Robin Patel
Journal: J Infect Dis Date: 2006-07-28 Impact factor: 5.226

4. In vitro biofilm characterization and activity of antifungal agents alone and in combination against sessile and planktonic clinical Candida albicans isolates.

Authors: Jennifer A Shuford; Kerryl E Piper; James M Steckelberg; Robin Patel
Journal: Diagn Microbiol Infect Dis Date: 2006-12-01 Impact factor: 2.803

5. In vitro activity of caspofungin against Candida albicans biofilms.

Authors: Stefano P Bachmann; Kacy VandeWalle; Gordon Ramage; Thomas F Patterson; Brian L Wickes; John R Graybill; José L López-Ribot
Journal: Antimicrob Agents Chemother Date: 2002-11 Impact factor: 5.191

6. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance.

Authors: J Chandra; D M Kuhn; P K Mukherjee; L L Hoyer; T McCormick; M A Ghannoum
Journal: J Bacteriol Date: 2001-09 Impact factor: 3.490

7. Species-specific differences in the susceptibilities of biofilms formed by Candida bloodstream isolates to echinocandin antifungals.

Authors: Hyun Woo Choi; Jong Hee Shin; Sook In Jung; Kyung Hwa Park; Duck Cho; Seung Jung Kee; Myung Geun Shin; Soon Pal Suh; Dong Wook Ryang
Journal: Antimicrob Agents Chemother Date: 2007-02-05 Impact factor: 5.191

8. Biofilm formation by Candida species on the surface of catheter materials in vitro.

Authors: S P Hawser; L J Douglas
Journal: Infect Immun Date: 1994-03 Impact factor: 3.441

8 in total

13 in total

1. In vitro activity of micafungin against planktonic and sessile Candida albicans isolates.

Authors: Melissa J Jacobson; Kathryn E Steckelberg; Kerryl E Piper; James M Steckelberg; Robin Patel
Journal: Antimicrob Agents Chemother Date: 2009-03-23 Impact factor: 5.191

2. Micafungin at physiological serum concentrations shows antifungal activity against Candida albicans and Candida parapsilosis biofilms.

Authors: M Guembe; J Guinea; L J Marcos-Zambrano; A Fernández-Cruz; T Peláez; P Muñoz; E Bouza
Journal: Antimicrob Agents Chemother Date: 2014-06-23 Impact factor: 5.191

3. In vitro assessment of the antifungal and paradoxical activity of different echinocandins against Candida tropicalis biofilms.

Authors: Tsun Sheng N Ku; Stella M Bernardo; Samuel A Lee
Journal: J Med Microbiol Date: 2011-06-23 Impact factor: 2.472

4. In vitro activities of anidulafungin and other antifungal agents against biofilms formed by clinical isolates of different Candida and Aspergillus species.

Authors: Barbara Fiori; Brunella Posteraro; Riccardo Torelli; Mario Tumbarello; David S Perlin; Giovanni Fadda; Maurizio Sanguinetti
Journal: Antimicrob Agents Chemother Date: 2011-03-21 Impact factor: 5.191

Review 5. Echinocandin antifungal drugs in fungal infections: a comparison.

Authors: Sharon C-A Chen; Monica A Slavin; Tania C Sorrell
Journal: Drugs Date: 2011-01-01 Impact factor: 9.546

6. Characterization of Candida parapsilosis complex strains isolated from invasive fungal infections.

Authors: E Borghi; R Sciota; R Iatta; C Biassoni; M T Montagna; G Morace
Journal: Eur J Clin Microbiol Infect Dis Date: 2011-04-10 Impact factor: 3.267

7. Interactions between human phagocytes and Candida albicans biofilms alone and in combination with antifungal agents.

Authors: Aspasia Katragkou; Michael J Kruhlak; Maria Simitsopoulou; Athanasios Chatzimoschou; Anna Taparkou; Catherine J Cotten; Fotini Paliogianni; Eudoxia Diza-Mataftsi; Chaido Tsantali; Thomas J Walsh; Emmanuel Roilides
Journal: J Infect Dis Date: 2010-06-15 Impact factor: 5.226